Education

Watch “The Science Behind Gene Therapy,” from ASGCT and NORD

ASGCT Staff - October 08, 2019

The webinars in this series are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

The second in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.

This session, held on Sept. 25, explored how gene therapies are developed, the ways in which evidence-based science guides manufacturers of gene therapies, how vectors deliver gene therapies to cells, and what happens inside the body after gene therapy is delivered. Speakers include Sven Kili, M.D., a member of the ASGCT Outreach and Communications Committee and a strategic consultant for regenerative medicine companies, and Tiffany Lucas, Ph.D., an FDA product reviewer in the division of gene therapy in the Center for Biologics Evaluation and Research (CBER).

Mark your calendar for the rest of the sessions in this free webinar series. All the webinars are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

  • The FDA’s Role in Gene Therapy—Wednesday, October 30
  • Understanding the Gene Therapy Process and Aftercare – Wednesday, November 20
  • Life After Gene Therapy – Wednesday, December 18

The first webinar, “Gene Therapy: Yesterday, Today and Tomorrow,” is available for free here.

Share This Page

Related Articles

Education

ASGCT Releases Patient Education Resources on Sickle Cell Disease

ASGCT Staff - September 21, 2020
Education

ASGCT Releases Patient Education Resources on Vectors

ASGCT Staff - September 09, 2020
Education

ASGCT Launches New Patient Education Site With More Resources

ASGCT Staff - September 01, 2020
Education

Can Gene Therapy Help Treat Sickle Cell Disease?

Emily Nettesheim - June 23, 2020